David E. Sternberg

1.8k total citations
28 papers, 1.4k citations indexed

About

David E. Sternberg is a scholar working on Psychiatry and Mental health, Molecular Biology and Pharmacology. According to data from OpenAlex, David E. Sternberg has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in David E. Sternberg's work include Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (7 papers) and Tryptophan and brain disorders (6 papers). David E. Sternberg is often cited by papers focused on Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (7 papers) and Tryptophan and brain disorders (6 papers). David E. Sternberg collaborates with scholars based in United States and Czechia. David E. Sternberg's co-authors include George R. Heninger, Dennis S. Charney, John F. Reinhard, George R. Heninger, D. Harold Landis, Stephen R. Marder, Henry H. Holcomb, Daniël P. van Kammen, Ronald O. Rieder and Markku Linnoila and has published in prestigious journals such as Science, American Journal of Psychiatry and The British Journal of Psychiatry.

In The Last Decade

David E. Sternberg

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Sternberg United States 20 598 448 338 254 244 28 1.4k
P. Moleman Netherlands 22 459 0.8× 449 1.0× 357 1.1× 219 0.9× 120 0.5× 68 1.8k
Keith G. Kramlinger United States 13 649 1.1× 313 0.7× 298 0.9× 186 0.7× 126 0.5× 17 1.5k
David Pickar United States 17 599 1.0× 553 1.2× 328 1.0× 295 1.2× 485 2.0× 19 1.7k
Goodwin Fk United States 18 413 0.7× 311 0.7× 244 0.7× 133 0.5× 138 0.6× 44 1.1k
J. E. Christie United Kingdom 20 501 0.8× 289 0.6× 422 1.2× 475 1.9× 149 0.6× 42 1.9k
I‐Shin Shiah Taiwan 20 466 0.8× 399 0.9× 295 0.9× 185 0.7× 218 0.9× 51 1.4k
Jan Balldin Sweden 25 618 1.0× 577 1.3× 294 0.9× 141 0.6× 158 0.6× 79 1.9k
N. Matussek Germany 18 380 0.6× 378 0.8× 308 0.9× 118 0.5× 155 0.6× 70 1.3k
M. Khaled El‐Yousef United States 11 372 0.6× 448 1.0× 345 1.0× 277 1.1× 127 0.5× 24 1.2k
R M Post United States 20 1.1k 1.9× 285 0.6× 388 1.1× 263 1.0× 351 1.4× 27 2.2k

Countries citing papers authored by David E. Sternberg

Since Specialization
Citations

This map shows the geographic impact of David E. Sternberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Sternberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Sternberg more than expected).

Fields of papers citing papers by David E. Sternberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Sternberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Sternberg. The network helps show where David E. Sternberg may publish in the future.

Co-authorship network of co-authors of David E. Sternberg

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Sternberg. A scholar is included among the top collaborators of David E. Sternberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Sternberg. David E. Sternberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osawa, Yoko, Dingbang Xu, David E. Sternberg, et al.. (2006). Functional expression of the GABAB receptor in human airway smooth muscle. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(5). L923–L931. 37 indexed citations
2.
Sternberg, David E.. (1987). Dr. Sternberg Replies. American Journal of Psychiatry. 144(8). 1104–a. 2 indexed citations
3.
Sternberg, David E.. (1986). Testing for physical illness in psychiatric patients.. PubMed. 47(1 Suppl). 3–9. 37 indexed citations
4.
Innis, Robert B., Benjamin S. Bunney, Dennis S. Charney, et al.. (1986). Does the cholecystokinin antagonist proglumide possess antipsychotic activity?. Psychiatry Research. 18(1). 1–7. 19 indexed citations
5.
Heninger, George R., Dennis S. Charney, & David E. Sternberg. (1984). Lithium carbonate augmentation of antidepressant treatment. Journal of Clinical Psychopharmacology. 4(3). 167–167. 80 indexed citations
6.
Charney, Dennis S., George R. Heninger, & David E. Sternberg. (1984). The Effect of Mianserin on Alpha-2 Adrenergic Receptor Function in Depressed Patients. The British Journal of Psychiatry. 144(4). 407–416. 31 indexed citations
7.
Kammen, Daniël P. van, Lee S. Mann, David E. Sternberg, et al.. (1983). Dopamine-β-Hydroxylase Activity and Homovanillic Acid in Spinal Fluid of Schizophrenics with Brain Atrophy. Science. 220(4600). 974–977. 107 indexed citations
8.
Holcomb, Henry H., David E. Sternberg, & George R. Heninger. (1983). Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.. PubMed. 18(8). 865–73. 57 indexed citations
9.
Sternberg, David E., Malcolm B. Bowers, George R. Heninger, & Dennis S. Charney. (1983). Lithium prevents adaptation of brain dopamine systems to haloperidol in schizophrenic patients. Psychiatry Research. 10(2). 79–86. 31 indexed citations
10.
Charney, Dennis S., George R. Heninger, & David E. Sternberg. (1982). Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine. Life Sciences. 30(23). 2033–2041. 108 indexed citations
11.
Charney, Dennis S., et al.. (1982). The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects. Psychopharmacology. 77(3). 217–222. 88 indexed citations
12.
Charney, Dennis S., George R. Heninger, David E. Sternberg, & D. Harold Landis. (1982). Abrupt Discontinuation of Tricyclic Antidepressant Drugs: Evidence for Noradrenergic Hyperactivity. The British Journal of Psychiatry. 141(4). 377–386. 94 indexed citations
13.
Charney, Dennis S., George R. Heninger, & David E. Sternberg. (1982). Failure of chronic antidepressant treatment to alter growth hormone response to clonidine. Psychiatry Research. 7(2). 135–138. 34 indexed citations
14.
Garbutt, James C., Daniël P. van Kammen, Robert A. Levine, et al.. (1982). Cerebrospinal fluid hydroxylase cofactor in schizophrenia. Psychiatry Research. 6(2). 145–151. 12 indexed citations
15.
Charney, Dennis S., et al.. (1982). The effect of IV l-tryptophan on prolactin, growth hormone, and mood in healthy subjects. Psychopharmacology. 78(1). 38–43. 41 indexed citations
16.
Sternberg, David E., et al.. (1981). The effect of pimozide on CSF norepinephrine in schizophrenia. American Journal of Psychiatry. 138(8). 1045–1050. 56 indexed citations
17.
Charney, Dennis S., George R. Heninger, David E. Sternberg, & Robert H. Roth. (1981). Plasma MHPG in depression: Effects of acute and chronic desipramine treatment. Psychiatry Research. 5(2). 217–229. 44 indexed citations
18.
Lake, C R, David E. Sternberg, Daniël P. van Kammen, et al.. (1980). Response : Elevated Cerebrospinal Fluid Norepinephrine in Schizophrenics: Confounding Effects of Treatment Drugs. Science. 210(4465). 97–97. 1 indexed citations
19.
Kammen, Daniël P. van, David E. Sternberg, Theodore A. Hare, et al.. (1980). Schizophrenia: Low spinal fluid GABA levels?. Brain Research Bulletin. 5. 731–735. 9 indexed citations
20.
Sternberg, David E.. (1976). Memory Functions in Depression. Archives of General Psychiatry. 33(2). 219–219. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Moleman Breakdown of academic impact, for papers by Keith G. Kramlinger Breakdown of academic impact, for papers by David Pickar Breakdown of academic impact, for papers by Goodwin Fk Breakdown of academic impact, for papers by J. E. Christie Breakdown of academic impact, for papers by I‐Shin Shiah Breakdown of academic impact, for papers by Jan Balldin Breakdown of academic impact, for papers by N. Matussek Breakdown of academic impact, for papers by M. Khaled El‐Yousef Breakdown of academic impact, for papers by R M Post
Rankless by CCL
2026